Utah Medical Products, Inc.UTMDNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P41
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -2.53% |
| Q3 2025 | -14.13% |
| Q2 2025 | 0.00% |
| Q1 2025 | 6.98% |
| Q4 2024 | -15.69% |
| Q3 2024 | 7.37% |
| Q2 2024 | -12.84% |
| Q1 2024 | -7.63% |
| Q4 2023 | 9.26% |
| Q3 2023 | -6.90% |
| Q2 2023 | 0.00% |
| Q1 2023 | -7.94% |
| Q4 2022 | 6.78% |
| Q3 2022 | 4.42% |
| Q2 2022 | 16.49% |
| Q1 2022 | -14.16% |
| Q4 2021 | -1.74% |
| Q3 2021 | 22.34% |
| Q2 2021 | 13.25% |
| Q1 2021 | -11.70% |
| Q4 2020 | 16.05% |
| Q3 2020 | 125.00% |
| Q2 2020 | -57.65% |
| Q1 2020 | -27.35% |
| Q4 2019 | 17.00% |
| Q3 2019 | 5.26% |
| Q2 2019 | 13.10% |
| Q1 2019 | -7.69% |
| Q4 2018 | -49.72% |
| Q3 2018 | 57.39% |
| Q2 2018 | 4.55% |
| Q1 2018 | 264.18% |
| Q4 2017 | -169.07% |
| Q3 2017 | -6.73% |
| Q2 2017 | 9.47% |
| Q1 2017 | 30.14% |
| Q4 2016 | -6.41% |
| Q3 2016 | -10.34% |
| Q2 2016 | 1.16% |
| Q1 2016 | 1.18% |